Core Viewpoint - The company, Yipai Sunshine (02522), has entered into a placement agreement to issue 35 million shares at a price of HKD 16.76 per share, representing a discount of approximately 12.53% from the last trading price of HKD 19.16 on August 21, 2025 [1] Summary by Categories Placement Details - The placement involves a total of 35 million shares, which accounts for about 11.93% of the company's issued H-shares as of the announcement date [1] - The expected net proceeds from the placement, after deducting commissions and related costs, are approximately HKD 562 million [1] Use of Proceeds - Approximately 40% of the net proceeds will be allocated to the development of data and artificial intelligence, focusing on medical imaging data services and establishing strategic partnerships with leading companies and hospitals [1] - About 30% of the net proceeds will be used for expanding the company's medical imaging center business through investments or acquisitions, targeting both domestic and overseas markets [1] - Approximately 20% of the net proceeds will be invested in establishing an incubation fund for quality healthcare enterprises, enhancing the company's industry influence [1] - The remaining 10% of the net proceeds will be allocated for general working capital [1]

Core Viewpoint - The company, Yipai Sunshine (02522), has announced a placement agreement to issue 35 million shares at a price of HKD 16.76 per share, representing approximately 11.93% of the enlarged issued H shares as of the announcement date [1] Summary by Categories Placement Details - The placement price of HKD 16.76 per share reflects a discount of about 12.53% compared to the closing price of HKD 19.16 on August 21, 2025 [1] - The expected net proceeds from the placement, after deducting commissions and related costs, will be approximately HKD 562 million [1] Use of Proceeds - Approximately 40% of the net proceeds will be allocated to the development of data and artificial intelligence, focusing on medical imaging data mining, annotation, and cleaning services, as well as the development of AI application platforms [1] - About 30% of the net proceeds will be used for the expansion of the company's medical imaging center business and enabling solutions through self-investment or acquisitions, targeting both domestic and overseas markets such as Hong Kong and Singapore [1] - Approximately 20% of the net proceeds will be invested in or used to establish an industrial incubation fund to invest in quality healthcare companies and third parties that align with the group's business resources [1] - The remaining 10% of the net proceeds will be allocated for general working capital [1]

Core Viewpoint - The company, Yipai Yangguang (02522.HK), has announced a placement agreement to issue 35 million shares at a price of HKD 16.76 per share, which represents approximately 13.55% of the existing H-shares and 9.58% of the total issued shares as of the announcement date [1][2]. Group 1 - The placement is expected to raise approximately HKD 586.6 million in total proceeds, with a net amount of about HKD 562.1 million after expenses [2]. - The net proceeds from the placement will be allocated as follows: approximately 40% for the development of data and artificial intelligence in medical imaging, 30% for expanding the medical imaging center business through investments or acquisitions, 20% for establishing an incubation fund for quality healthcare enterprises, and 10% for general working capital [2]. Group 2 - The company aims to deepen its capabilities in data services related to medical imaging by collaborating with leading enterprises in AI and healthcare, as well as major hospitals in China [2]. - The strategic focus includes establishing a data space and creating a convertible imaging center, while also building an investment portfolio in high-quality enterprises within the medical field [2].